• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性肌炎和皮肌炎的早期治疗效果。

Effect of early treatment in polymyositis and dermatomyositis.

机构信息

Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Neurol India. 2010 Jan-Feb;58(1):58-61. doi: 10.4103/0028-3886.60398.

DOI:10.4103/0028-3886.60398
PMID:20228465
Abstract

BACKGROUND

Idiopathic inflammatory myopathies, dermatomyositis (DM) and polymyositis (PM) are rare but are potentially treatable.

AIM

To compare the effect of early and late treatment in patients with PM and DM.

MATERIALS AND METHODS

The study included all the adult patients with definite diagnosis of PM or DM treated for at least 12 months. The patients were divided into two groups: Early Group - treatment within three months and Late Group - treatment after three months. The number of patients with positive therapeutic response, remission in less than one year and the mean time elapsed for reaching the remission were assessed and compared between the two groups. Chi-square test, Fisher's exact test, t-test and Pearson correlation test were used for data analysis.

RESULTS

The analysis included 65 patients, 42 with DM and 23 with PM. Late Group included 24 patients (seven PM and 17 DM), while Early Group included 41 patients (16 PM and 25 DM). Positive therapeutic response, remission rate within one year was higher in Early Group (80% vs. 46%, P: 0.004). The mean time needed to achieve remission was much less with early treatment (5.5 vs. 11.9 months, P: 0.003). The relapse rate was also lower in Early Group (5% vs. 25%, P < 0.02). The comparison of treatment outcomes showed the same results in both PM and DM, but it was statistically significant in patients with DM.

CONCLUSIONS

Early treatment in patients with PM and DM is associated with higher remission rates, shorter treatment period and low complication rates.

摘要

背景

特发性炎性肌病、皮肌炎(DM)和多发性肌炎(PM)较为罕见,但具有潜在可治性。

目的

比较 PM 和 DM 患者早期和晚期治疗的效果。

材料与方法

本研究纳入了所有接受至少 12 个月治疗的明确诊断为 PM 或 DM 的成年患者。将患者分为两组:早期组-治疗在三个月内;晚期组-治疗在三个月后。评估并比较两组患者的治疗反应阳性、一年内缓解和达到缓解的平均时间。采用卡方检验、Fisher 确切检验、t 检验和 Pearson 相关检验进行数据分析。

结果

分析纳入 65 例患者,其中 42 例为 DM,23 例为 PM。晚期组包括 24 例(7 例 PM 和 17 例 DM),而早期组包括 41 例(16 例 PM 和 25 例 DM)。早期组的治疗反应阳性率和一年内缓解率更高(80%比 46%,P:0.004)。早期治疗达到缓解所需的平均时间更短(5.5 比 11.9 个月,P:0.003)。早期组的复发率也较低(5%比 25%,P < 0.02)。治疗结果比较在 PM 和 DM 患者中均显示出相同的结果,但在 DM 患者中具有统计学意义。

结论

PM 和 DM 患者的早期治疗与更高的缓解率、更短的治疗期和更低的并发症发生率相关。

相似文献

1
Effect of early treatment in polymyositis and dermatomyositis.多发性肌炎和皮肌炎的早期治疗效果。
Neurol India. 2010 Jan-Feb;58(1):58-61. doi: 10.4103/0028-3886.60398.
2
Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.皮肌炎/多肌炎中对皮质类固醇耐药的间质性肺炎:环孢素的预测及治疗
J Rheumatol. 1999 Jul;26(7):1527-33.
3
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.多发性肌炎和皮肌炎:短期和长期预后以及预后的预测因素。
J Rheumatol. 2001 Oct;28(10):2230-7.
4
[The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].[多发性肌炎/皮肌炎患者间质性肺疾病的预测因素及不良预后因素]
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Jun;31(6):417-20.
5
Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.多发性肌炎和皮肌炎间肺间质疾病的临床特征及预后差异
J Rheumatol. 2005 Jan;32(1):58-64.
6
[Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].多肌炎和皮肌炎的临床与病理研究:83例报告
Di Yi Jun Yi Da Xue Xue Bao. 2002 Dec;22(12):1139-40.
7
[Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].[多发性肌炎和皮肌炎合并纵隔气肿的临床分析]
Zhonghua Yi Xue Za Zhi. 2006 Mar 7;86(9):624-7.
8
Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.环孢素A治疗难治性成人多发性肌炎/皮肌炎:6例患者的基于人群的经验及文献综述
J Rheumatol. 2000 Dec;27(12):2855-9.
9
Rituximab as therapy for refractory polymyositis and dermatomyositis.利妥昔单抗治疗难治性多发性肌炎和皮肌炎。
J Rheumatol. 2006 May;33(5):1021-6. Epub 2006 Mar 15.
10
[Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].[全国范围内关于环孢素A治疗胶原病相关间质性肺炎的调查]
Ryumachi. 1999 Dec;39(6):819-28.

引用本文的文献

1
Rheumatology training and research in Iran.伊朗的风湿病学培训与研究。
Rheumatol Int. 2019 Aug;39(8):1307-1319. doi: 10.1007/s00296-019-04325-5. Epub 2019 May 20.
2
Increased Cumulative Incidence of Dermatomyositis in Ulcerative Colitis: a Nationwide Cohort Study.溃疡性结肠炎患者皮肌炎累积发病率增加:一项全国性队列研究
Sci Rep. 2016 Jun 21;6:28175. doi: 10.1038/srep28175.
3
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.幼年特发性皮肌炎临床无活动疾病的 PRINTO 标准。
Ann Rheum Dis. 2013 May;72(5):686-93. doi: 10.1136/annrheumdis-2012-201483. Epub 2012 Jun 26.